Ackerman John 4

What Happened
John Ackerman, a director of Guardian Pharmacy Services, Inc. (GRDN), sold a total of 1,103,364 Class A shares on March 20, 2026. The sales were recorded as two dispositions: 827,636 shares and 275,728 shares, each at $29.68 per share, bringing total gross proceeds of $32,750,602. This was a sale (S), not a purchase — sales by insiders are often routine and do not by themselves signal company outlook.

Key Details

• Transaction date: March 20, 2026. Report filed on March 24, 2026 (appears to be filed within the standard 2-business-day window).
• Price(s): $29.68 per share for both reported dispositions.
• Shares sold: 827,636 and 275,728 (total 1,103,364). Total proceeds: $32,750,602.
• Security: Class A common stock, $0.001 par value.
• Footnote: The shares “were sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders and BofA Securities, Inc. and Jefferies LLC,” indicating the sales were arranged with underwriters.
• Post-transaction holdings: Not specified in the provided filing excerpt.

Context
Although the Form 4 lists the transactions as open market/private sales (code S), the footnote specifies the disposition was pursuant to an underwriting agreement with BofA and Jefferies, which typically reflects a secondary or underwritten block sale arranged with underwriters rather than a routine small open-market trade. Sales by directors can be part of pre-arranged offerings or liquidity events; they are not, by themselves, proof of insider sentiment.